Plaque Psoriasis
📧 Sign up to get email alerts when something new happens for Plaque Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Study to Evaluate Safety,Tolerability,Pharmacodynamics & Pharmacokinetics of JTE-451 in Active Plaque Psoriasis Subjects [Phase 1]
This clinical trial update reports on a Phase 1 study evaluating safety, tolerability, pharmacodynamics, and pharmacokinetics of JTE-451 in …
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: Non-interventional Study of the Effect of Smoking Status of the Patient on the Success of Etanercept Therapy in Psoriasis
An observational, non-interventional study evaluating whether smoking status affects the success of etanercept therapy in adults with plaque…
-
CLINICAL_TRIALS trial_result · 2017-06-27Clinical Trial Update: Open-label Study of Subcutaneous Secukinumab to Evaluate Efficacy and Safety in Patients With Plaque Psoriasis Who Had Inadequate Response to Cyclosporine A [Phase 4]
Phase 4 open-label study assessing subcutaneous secukinumab in plaque psoriasis patients with inadequate response to cyclosporine A; results…
-
CLINICAL_TRIALS trial_result · 2017-06-26Clinical Trial Update: A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis [Phase 3]
Phase 3 long-term safety and tolerability study of CP-690,550 (tofacitinib) in adults with moderate-to-severe chronic plaque psoriasis was t…
-
FDA approval · 2017-06-19FDA Approved: TACLONEX — Supplemental Application (LEO Pharma Inc.)
The FDA approved a supplemental application for Taclonex (calcipotriene and betamethone dipropionate) from LEO Pharma Inc., under NDA 022185…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-06-09Clinical Trial Update: Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque Psoriasis [Phase 1]
Phase 1 clinical trial completed evaluating topically applied IDP-118 Lotion and HP Monad Lotion in adults with moderate to severe plaque ps…
-
FDA label_change · 2017-06-08FDA Approved: SILIQ — Supplemental Application (Bausch Health US LLC)
FDA approved a supplemental application for SILIQ (brodalumab) filed by Bausch Health US LLC.
-
CLINICAL_TRIALS research · 2017-06-08Clinical Trial Update: Evaluation of Efficacy, Duration of Remission and Safety of a Light and Occlusive Patch Therapy for Plaque Psoriasis [NA]
Clinical trial update evaluating the efficacy, duration of remission, and safety of a light and occlusive patch therapy for plaque psoriasis…
-
CLINICAL_TRIALS trial_result · 2017-06-06Clinical Trial Update: A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis. [Phase 4]
Phase 4 study update evaluating efficacy and safety of apremilast in moderate plaque psoriasis; study completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Study of Safety and Efficacy of Topical GSK2981278 Ointment in Plaque Psoriasis [Phase 1]
A completed Phase 1 study evaluating the safety and potential efficacy of a topical GSK2981278 ointment for plaque psoriasis.
-
FDA approval · 2017-04-21FDA Approved: RENFLEXIS — Original Application (Organon LLC)
The FDA approved RENFLEXIS (infliximab) from Organon LLC based on an original application, making it a biosimilar to Remicade. The approval …
-
CLINICAL_TRIALS trial_result · 2017-04-13Clinical Trial Update: Bioavailability of AZD0284 and IV Microtracer Study [Phase 1]
Phase 1 bioavailability study of AZD0284 with an IV microtracer has completed in patients with plaque psoriasis.
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira [Phase 3]
Phase 3 study comparing the biosimilar GP2017 to Humira in plaque psoriasis completed; results posted in 2017. The results indicate equivale…
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: Efficacy and Safety of Namilumab (MT203) for Plaque Psoriasis [Phase 2]
Phase 2 study of namilumab (MT203) for plaque psoriasis completed with posted efficacy and safety results.
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: A Double Blind Study in Pediatric Subjects With Chronic Plaque Psoriasis, Studying Adalimumab vs. Methotrexate [Phase 3]
Phase 3 pediatric trial comparing adalimumab to methotrexate in chronic plaque psoriasis; study completed with results posted in 2017.
-
FDA approval · 2017-04-03FDA Approved: TAZAROTENE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' generic tazarotene via an original ANDA submission.
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: Plaque Psoriasis Study in Pediatric Subjects [Phase 4]
A phase 4 pediatric trial update for plaque psoriasis has completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: PK and PD Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis [Phase 4]
A Phase 4 PK/PD study in pediatric subjects evaluates Calcitriol 3 mcg/g ointment for plaque psoriasis with completed results posted.
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Etanercept (GP2015) and Enbrel [Phase 3]
Phase 3 trial update showing equivalent efficacy and safety between biosimilar GP2015 and Enbrel (etanercept) in chronic plaque psoriasis. R…
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: A Study to Assess the Severity of Psoriasis in Brazilians Participants With Chronic Plaque-type Psoriasis
This clinical trial completed and reported results assessing psoriasis severity in Brazilian participants with chronic plaque-type psoriasis…
-
FDA approval · 2017-03-20FDA Approved: CLOBETASOL PROPIONATE — Original Application (Northstar Rx LLC)
FDA approved the original application for a generic clobetasol propionate topical corticosteroid, manufactured by Northstar Rx LLC. The appr…
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: A Clinical Study of Increased Dose of TA-650 in Patients With Psoriasis [Phase 3]
A Phase 3 study of an increased dose of TA-650 in patients with plaque psoriasis and related psoriatic conditions has completed, with result…
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: DFD01 Spray vs Comp01 Lotion HPA Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis [Phase 2]
Phase 2 trial update comparing DFD01 spray to Comp01 lotion in patients with plaque psoriasis; study completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-03-08Clinical Trial Update: A Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06700841, With Bioavailability/Food Effect Investigation [Phase 1]
Phase 1 study evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of PF-06700841, including a bioavailability/food-effect…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Efficacy and Tolerability of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis [Phase 1, Phase 2]
Phase 1/2 trial comparing HAT1 to Calcipotriol in adults with mild-to-moderate chronic plaque psoriasis reports on efficacy and tolerability…